Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of a PD-1 antagonist and a VEGFR inhibitor for treating cancer

Combination of a PD-1 antagonist and a VEGFR inhibitor for treating cancer

US Patent 10570202 · Granted Feb 25, 2020

Estimated economic value: $319,877,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for tumor immunotherapy2025
Combination of a PD-1 antagonist and a listeria-based vaccine for treating prost2018
Combination of a PD-1 antagonist and a listeria-based vaccine for treating prost2018
Method of using PI3K and MEK modulators2014
Predictors of patient response to treatment with EGF receptor inhibitors2012